# Anastasia Hughes

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/anastasia-hughes/

## Facts

| Field | Value |
| --- | --- |
| Citations | 328 |
| Field | Dialysis and Renal Disease Management |
| h-index | 8 |
| i10-index | 7 |
| Last Known Institution | The University of Sydney |
| OpenAlex ID | https://openalex.org/A5078857171 |
| ORCID iD | 0009-0003-5512-0333 |
| Works | 46 |

## Researcher papers

- [Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy](https://scholariq.org/papers/preclinical-efficacy-of-azacitidine-and-venetoclax-for-infant-kmt2a-rearranged/)
- [New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment](https://scholariq.org/papers/new-therapeutic-opportunities-from-dissecting-the-pre-b-leukemia-bone-marrow/)
- [The bone marrow microenvironment of pre-B acute lymphoblastic leukemia at single-cell resolution](https://scholariq.org/papers/the-bone-marrow-microenvironment-of-pre-b-acute-lymphoblastic-leukemia-at-single/)
- [Therapeutic Targeting of the Leukaemia Microenvironment](https://scholariq.org/papers/therapeutic-targeting-of-the-leukaemia-microenvironment/)
- [The Bone Marrow Microenvironment in B-Cell Development and Malignancy](https://scholariq.org/papers/the-bone-marrow-microenvironment-in-b-cell-development-and-malignancy/)
- [Preclinical Evaluation of Carfilzomib for Infant KMT2A-Rearranged Acute Lymphoblastic Leukemia](https://scholariq.org/papers/preclinical-evaluation-of-carfilzomib-for-infant-kmt2a-rearranged-acute/)
- [Romidepsin enhances the efficacy of cytarabine <i>in vivo</i>, revealing histone deacetylase inhibition as a promising therapeutic strategy for <i>KMT2A</i>-rearranged infant acute lymphoblastic leukemia](https://scholariq.org/papers/romidepsin-enhances-the-efficacy-of-cytarabine-i-in-vivo-i-revealing-histone/)
- [Perceptions of a prescription model for accessing nicotine vaping products: an examination of submissions made by self-reported e-cigarette users to an Australian consultation](https://scholariq.org/papers/perceptions-of-a-prescription-model-for-accessing-nicotine-vaping-products-an/)
- [Characterization of mesenchymal stem cells in pre-B acute lymphoblastic leukemia](https://scholariq.org/papers/characterization-of-mesenchymal-stem-cells-in-pre-b-acute-lymphoblastic-leukemia/)
- [Perspectives and Experiences of Patients with AKI](https://scholariq.org/papers/perspectives-and-experiences-of-patients-with-aki/)
- [Core Patient-Reported Outcomes for Trials in Nephrology](https://scholariq.org/papers/core-patient-reported-outcomes-for-trials-in-nephrology/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Researcher university

- [The University of Sydney](https://scholariq.org/institutions/the-university-of-sydney/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.